Gene Therapy and Diagnostics for Personalized Medicine in Neurodegenerative Diseases at Michigan State University
Slowing disease progression. Improving quality of life. Lowering health care costs.
A diagnosis of Parkinson’s disease (PD) or other neurodegenerative disorder can be devastating for patients and caregivers. These diseases take a toll on a patient’s body and cognitive processes, and drug therapies used to treat symptoms can sometimes cause adverse reactions, limiting therapeutic effectiveness and length of treatment.
A portfolio of novel technologies developed by leading researchers at MSU offers new hope: these technologies may improve diagnosis, treatment, and quality of life for patients suffering from neurodegenerative diseases and the negative side effects associated with standard treatments. They provide the potential to both aid symptoms and actually modify these diseases, slowing down—and in some cases even halting—their progression.
Specifically targeted at PD treatment, these gene therapies and diagnostics also hold promise for other neurodegenerative disorders, such as Huntington’s disease, Alzheimer’s disease, and Amyotrophic Lateral Sclerosis (ALS).